# SMS Pharmaceuticals Ltd (SMSPHARMA)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹381.45
Day Change: -10.43%
52W High: ₹447.8
52W Low: ₹207.7
Market Cap: ₹3,727 Cr

## Valuation
P/E: 39.76
P/B: 4.86
EPS: ₹10.01
Book Value: ₹81.83
Dividend Yield: 0%

## Returns
1Y Return: 38.24%

## Profitability
ROE: 0%
ROCE: 15.9%
Debt/Equity: 0.44
Revenue Growth: 21.4%
Profit Growth: 20.5%
EBITDA Margin: 18.95%
Operating Margin: 15.98%

## About
SMS Pharmaceuticals Ltd is a Drug Manufacturers - General company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - General
Sub Industry: Unknown

## Business Model
Overview: SMS Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - General. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Quarterly Report: Board Meeting Intimation for Approval Of Financial Results For The Quarter And Financial Year Ended 31St March, 2026
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:15.406Z
Price History Updated: 2026-05-18T22:58:42.428Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:42.428Z
Quant Updated: 2026-05-18T22:58:42.428Z
Sentiment Updated: 2026-05-18T22:58:42.428Z
Financials Status: current
Financials Updated: 2026-05-18T14:30:29.406Z
Financials Last Attempt: 2026-05-18T14:30:29.406Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2016)
Revenue: ₹193 Cr
Operating Profit: ₹47 Cr (OPM 25%)
Net Profit: ₹25 Cr
Tax: ₹40 Cr

## Annual P&L History
Mar 2016: Rev ₹193Cr | PAT ₹25Cr | OPM 25%
Mar 2017: Rev ₹611Cr | PAT ₹41Cr | OPM 15%
Mar 2018: Rev ₹438Cr | PAT ₹28Cr | OPM 17%

## Balance Sheet (Mar 2016)
Total Assets: ₹329 Cr
Total Liabilities: ₹329 Cr
Borrowings: ₹73 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Ramesh Babu Potluri, Chairman & MD
- Lakshmi Narayana Tammineedi, Chief Financial Officer
- Tumma  Thirumalesh, Company Secretary & Compliance Officer
- Vamsi Krishna Potluri, Executive Director
- NHD  Prasad, Vice President of Operations

---
Source: rupiya.io/stocks/smspharma
Disclaimer: For research and education only. Not investment advice.